Pfizer, Moderna COVID-19 vaccines may be ready for U.S. authorization within weeks: U.S. official

Nov 18 (Reuters) - Pfizer Inc’s and Moderna Inc’s COVID-19 vaccine candidates could be ready for U.S. authorization and distribution within weeks, setting the stage for widespread inoculation to begin as soon as this year, U.S. Health and Human Services Secretary Alex Azar said during a press call on Wednesday.

Officials said that states and territories are prepared to begin distributing the vaccines within 24 hours of receiving regulatory authorization and that complex cold storage requirements will not be an impediment to all Americans being able to access the vaccines. (Reporting by Manojna Maddipatla in Bengaluru Editing by Chizu Nomiyama)


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.